ST
Healthcare & Life Sciences
Storm Therapeutics
United Kingdomstormtherapeutics.com
Storm Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C.
Activeseries-c
series-c
Stage
About Storm Therapeutics
Storm Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series C. Brouky classifies it under Healthcare & Life Sciences.
Storm Therapeutics develops small molecule inhibitors targeting RNA modifying enzymes, focusing on their lead drug STC-15, a first-in-class METTL3 inhibitor in clinical trials for treating sarcoma.
Explore Storm Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.